Skip to Content

Thiothixene Capsules

Last Updated: July 1, 2014
Status: Resolved

Products Affected - Description

Thiothixene capsules

Reason for the Shortage

  • Pfizer discontinued Navane (thiothixene) 2 mg, 10 mg, and 20 mg presentations in the fall of 2011. The Navane 5 mg presentation was discontinued previously.
  • Sandoz discontinued all thiothixene presentations in early-2012.
  • Mylan discontinued thiothixene 10 mg capsules in 1000 count in the first half of 2011 and discontinued thiothixene 2 mg and 5 mg capsules in 1000 count in early-April, 2012.
  • Mylan could not provide a reason for the shortage.

Available Products

Thiothixene capsules, Mylan
1 mg capsules, 100 count (NDC 00378-1001-01)
2 mg capsules, 100 count (NDC 00378-2002-01)
5 mg capsules, 100 count (NDC 00378-3005-01)

10 mg capsules, 100 count (NDC 00378-5010-01)

Thiothixene capsules, Mylan Institutional
2 mg capsules, 100 count, unit dose (NDC 51079-0587-20)
5 mg capsules, 100 count, unit dose (NDC 51079-0588-20)
10 mg capsules, 100 count, unit dose (NDC 51079-0589-20)

Estimated Resupply Dates

Mylan Institutional has thiothixene 10 mg capsules in 100 count unit dose on back order and the company estimates a release date of late-June 2014.

Related Shortages

Updated

July 1, 2014; May 30, 2014; May 13, 2014; May 6, 2014; April 22, 2014; April 3, 2014; March 18, 2014; February 19, 2014; January 24, 2014; December 12, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide